Vertex Pharmaceuticals Incorporated
Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Against its peers
Compare in full ›| VRTX | 095700.KQ | KRYS | ROIV | 1530.HK | BBIO | |
|---|---|---|---|---|---|---|
| Market cap | 139.16B | 94.14B | 9.21B | 27.61B | 37.99B | 15.17B |
| P/E (TTM) | 35.3 | — | 42.2 | — | 4.1 | — |
| Forward P/E | 27.5 | — | 34.0 | -27.5 | 11.2 | -225.0 |
| Price/book | 6.7 | — | 6.4 | 6.5 | 1.2 | -5.9 |
| Dividend yield | — | — | — | — | 1.69% | — |
| 1-year change | +27.28% | −60.56% | +52.61% | +78.15% | −51.32% | +18.15% |
| Today | +3.44% | +0.73% | +1.90% | +6.08% | +4.00% | +5.21% |
The closest companies by business and industry (Biotechnology). Prices may be delayed up to 20 min.
Latest news
All VRTX news ›Vertex outlines ~$30% adjusted EBITDA margin level in 2027 as it raises FY2026 adjusted EBITDA guidance to $217.9M-$219.9M
Vertex Q3 2026 earnings: revenue beat, 30.4% EBITDA margin, raised full-year guidance, and strong cloud growth. Earnings Call Insights: Vertex, Inc. (VERX) Q3 2026 “The third quarter was a very strong quarter for Vertex and importantly, it…
H.C. Wainwright Sticks to Their Buy Rating for Vertex Pharmaceuticals (VRTX)
The Globe and Mail In a report released today, Ananda Ghosh from H.C. Wainwright maintained a Buy rating on Vertex Pharmaceuticals, with a price target of $641.00. Ghosh covers the Healthcare sector, focusing on stocks such
Vertex to Participate in Upcoming Investor Conferences - November 4, 2026
BioSpace Vertex to Participate in Upcoming Investor Conferences - November 4, 2026 BOSTON--(BUSINESS WIRE)--Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced management participation in three upcoming investo
More from 1 other outlet
Vertex Pharmaceuticals (VRTX) Receives a Buy from TD Cowen
The Globe and Mail In a report released today, Phil Nadeau from TD Cowen maintained a Buy rating on Vertex Pharmaceuticals, with a price target of $575.00. According to TipRanks, Nadeau is a 4-star analyst with an average return of 6.0% and
Vertex Pharmaceuticals Incorporated 2026 Q3 - Results - Earnings Call Presentation
2026-11-05. The following slide deck was published by Vertex Pharmaceuticals Incorporated in conjunction with their 2026 Q3 earnings call. The following slide deck was published by Vertex Pharmaceuticals Incorporated in conjunction with…
Vertex, Inc. (VERX) Q3 2026 Earnings Call Transcript
Vertex, Inc. (VERX) Q3 2026 Earnings Call November 4, 2026 5:00 PM EST Joseph Crivelli - Vice President of Investor RelationsChristopher Young - CEO, President & DirectorJohn Schwab - Chief Financial Officer Good morning, and welcome to…
More from 1 other outlet
Vertex Pharmaceuticals Thrives on Higher Sales and Guidance
Since 2008, Vertex Pharmaceuticals, Inc. (VRTX) shares have received 43 outlier institutional inflow signals and gained over 1,738%. It’s no wonder VRTX shares are up 17% so far this year – and they could rise more. MoneyFlows data shows…
Watching This Rare-Disease Biotech as Hyperscalers Lead Post-Election Market
Voters hit data centers on Tuesday, but the companies that already own the capacity are the winners. The sharp overnight reversal gained traction at the open, and breadth is running at a robust 71% positive. For the first time in a long…
Vertex Reports Third Quarter 2026 Financial Results
— Achieved total revenue of $3.44 billion, a 12% increase compared to third quarter 2025 — — Raising full-year revenue guidance to $13.15 billion to $13.25 billion — — Established fourth commercial pillar in rare endocrine diseases with…
More from 1 other outlet
Vertex Pharmaceuticals Incorporated $VRTX Stock Acquired by Vise Technologies Inc.
Posted by Danessa Lincoln on Nov 4th, 2026 NASDAQ:VRTX opened at $530.76 on Wednesday. Vertex Pharmaceuticals Incorporated has a 52 week low of $403.16 and a 52 week high of $568.67. The firm has a 50 day moving average of $522.98 and a…
From the 4Search news index, newest first.
In the news
Mentioned with
People in the coverage
Themes
Most coverage from
- marketscreener.com32
- seekingalpha.com12
- themarketsdaily.com11
- fool.com10
- tradingview.com10
Finance and business coverage in the 4SEARCH.business news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 120 articles, not a forecast.